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Abstract
Doppler echocardiography is useful in the initial evaluation and long-term follow-up of patients with
pulmonary artery hypertension. Aerosolised iloprost has been shown to reduce pulmonary
pressure immediately after inhalation. We report the echocardiographic findings in a patient with
severe pulmonary hypertension, before and after the inhalation of aerosolized iloprost. These
findings illustrate the acute influence of iloprost in right and left ventricular hemodynamics and
morphology. These findings were reproduced in subsequent echocardiographic evaluations.
Introduction
Doppler echocardiography is useful in the initial evalua-
tion and long-term follow-up of patients with pulmonary
arterial hypertension [1,2].
Case presentation
A 21-year-old woman diagnosed with idiopathic pulmo-
nary hypertension since she was eleven, responsive to cal-
cium channel blockers, was referred for Cardiology
consultation at 23 weeks pregnancy. She was on nifed-
ipine and fraxiparine and Doppler echocardiography
revealed a dilated and hypertrophied right ventricle and a
peak tricuspid regurgitant jet velocity of 5.3 ms-1 with esti-
mated right ventricular systolic pressure (RVSP) of 122
mmHg. She was then started on 5.0 μg of nebulized ilo-
prost six times per day. At the 29th week of pregnancy
Doppler echocardiography was repeated before and
immediately after a single dose of 5 μg of iloprost. Postin-
halation acute assessment revealed not only a remarkable
reduction in RVSP but also an impressive change in car-
diac morphology as is evident from figures 1, 2 and 3 and
from two-dimensional and three-dimensional echocardi-
ography video clips (see Additional files 1, 2, 3 and 4).
These findings were reproduced in subsequent echocardi-
ographic evaluations and illustrate the acute hemody-
namic effects of iloprost nebulization in a patient with
severe pulmonary hypertension.
Conclusion
The findings that we describe showed the potential utility
of echocardiography in the evaluation of the acute effects
of drugs used in the treatment of pulmonary arterial
hypertension.
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Transthoracic echocardiogram showing left ventricle long and short axis views after iloprost nebulization Figure 2
Transthoracic echocardiogram showing left ventricle long and short axis views after iloprost nebulization. In the echocardio-
graphic evaluation after iloprost administration we can detect a reduction in right ventricular dimension, with a proportional 
increase in left ventricular dimension and performance. The correction of the septal shift secondary to right ventricular over-
load also contributes to a smaller right ventricle and expanded left ventricle.
Transthoracic echocardiogram showing left ventricle long and short axis views before iloprost nebulization Figure 1
Transthoracic echocardiogram showing left ventricle long and short axis views before iloprost nebulization. This echocardiog-
raphy reveals the severe right ventricular dilatation and hypertrophy. As the right ventricle undergoes dilation and hypertro-
phy, its crescentic shape is lost and the septum shifts leftward compressing the left ventricle. This septum shift leads to a 
proportional reduction in left ventricular dimension and impaired left ventricular systolic performance.Publish with BioMed Central    and   every 
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Additional material Acknowledgements
Written informed consent was obtained for publication from the patient.
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Additional file 1
Two-dimensional parasternal view before iloprost inhalation. Two-dimen-
sional parasternal long and short axis views before iloprost inhalation 
showing a small left ventricle with increased eccentricity index.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-5-41-S1.avi]
Additional file 2
Two-dimensional parasternal view after iloprost inhalation. Two-dimen-
sional parasternal long and short axis views after iloprost inhalation show-
ing near normal morphology of both ventricles.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-5-41-S2.avi]
Additional file 3
Three-dimensional parasternal view before iloprost inhalation. Three-
dimensional parasternal long axis view before iloprost inhalation showing 
a small left ventricle with increased eccentricity index.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-5-41-S3.avi]
Additional file 4
Three-dimensional parasternal view after iloprost inhalation. Three-
dimensional parasternal long axis view after iloprost inhalation showing 
near normal morphology of both ventricles.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-5-41-S4.avi]
M-mode tracing at the left ventricular level before (left) and after (right) iloprost nebulization Figure 3
M-mode tracing at the left ventricular level before (left) and after (right) iloprost nebulization. On the left hand side this short 
axis M-mode tracing shows the diastolic intraventricular septal shifting toward the left ventricle, leading to its marked underfill-
ing. On the right hand side of the figure we can observe the correction of the septal shift after iloprost nebulization.